首页> 外国专利> Antitumor compounds Activated by PAF comprising an amino Group and a cytotoxic cyclic Group and its Synthesis method

Antitumor compounds Activated by PAF comprising an amino Group and a cytotoxic cyclic Group and its Synthesis method

机译:PAF激活的含氨基和细胞毒性环基的抗肿瘤化合物及其合成方法

摘要

A formula compound (I) EMI file = "00034117 =" U1 "id =" 1 "IMF = JPEG or a pharmaceutically acceptable salt, wherein R1 represents an amino acrylic acid or an oligoformaldehyde group, and its amino terminal function can be determined as a terminal protection group, The terms carbamate and oligopropionic acid describe a fixed radical, an amino acid or an oligomer composed of up to 12 amino acids, which is directly proportional to the heterocyclic nitrogen atom through the Amida link; RA and Rb form a heterocyclic cyclic cyclic cyclic cyclic ring together with the adjacent N-C group. 3 to 8 members, saturated or unsaturated,optionally substituted and optionally fused with benzo or cyclohexane, in which one or two CH2 groups can also be replaced by NH, O or S, R4 represents H, C1-C6 alkyl, C3-C8 cycloalkyl, aryl or heteroaryl; and Cyt 'represents the residue of a cytotoxic or cytostatic compound; selected from the group consisting of: Anthracycline derivatives such as doxorubicin, methotrexate analogs such as methotrexate, pritrexima, trimetrexate, or DDMP, melphalan, cisplatin analogs such as cisplatin, JM216, JM335, bis (platinum) or carboplatin, purine analogs and pyrimidines such as citarbin, gemcitabine, azacitidine. 6-thioguanine,flurdarabine or 2-deoxycoformycin, and analogues of other chemotherapeutic agents such as 9-aminocamptothecin, D, L-aminoglutethimide, trimethoprim, pyrimethamine, mitomycin C, mitoxantrone, cyclophosphamamide, 5-fluorouracil, extramustine, podofilotoxin provided N2-ocetil-L-homoarginyl-L-tyrosyl-L-glutaminyl-L-seril-N- [2,3,6-trideoxy-1-O - [(1S, 3S) -1 are excluded , 2,3,4,6,11-hexohydro-3,5,12-trihydroxy-3- (hydroxyacetyl) -10-methoxy-6,11-dioxo-1-naphthacenyl] -. Alpha.-L-lixo- hexopyrans-3-yl] -L-prolinamide; and N2-acetyl-L-homoarginyl-L-tyrosyl-L-glutaminyl-L-seril-L-seril-N- [2,3,6-trideoxy-1-O - [(1S, 3S) -1.2 , 3,4,6,11-hexahydro-3,5,12-trihidroxi-3- (hidroxiacetil) -10-metoxi-6 11-dioxo-1-naftacenil - alfa -L-lixo-hexopiranos- 3-il -L-prolinamida
机译:式(I)的化合物: EMI文件=“ 00034117 =” U1“ id = 1” IMF = JPEG 或可药用盐,其中R1代表氨基丙烯酸或低聚甲醛基团,其氨基末端官能团可确定为末端保护基团,术语氨基甲酸酯和低聚丙酸描述了一个固定基团,一种氨基酸或由最多12个氨基酸组成的低聚物,它们通过Amida键与杂环氮原子成正比; RA和Rb形成杂环环环状3至8个饱和或不饱和成员,可任选取代并任选与苯并或环己烷稠合,其中一个或两个CH2基团也可被NH,O或S取代,R4代表H,C1 -C 6烷基,C 3 -C 8环烷基,芳基或杂芳基;并且Cyt'代表细胞毒性或抑制细胞生长的化合物的残基;选自下组:蒽环类衍生物,例如阿霉素,甲氨蝶呤类似物suc h为甲氨蝶呤,普雷特昔玛,曲美曲酯或DDMP,美法仑,顺铂类似物,例如顺铂,JM216,JM335,双(铂)或卡铂,嘌呤类似物和嘧啶,例如citarbin,吉西他滨,阿扎胞苷。 6-硫鸟嘌呤,氟达拉滨或2-脱氧考福霉素,以及其他化学治疗剂的类似物,例如9-氨基喜树碱,D,L-氨基谷氨酰胺,甲氧苄氨嘧啶,乙胺嘧啶,丝裂霉素C,米托蒽醌,环磷酰胺,5-氟尿嘧啶,肌外肽,足痛草毒素-L-高精氨酰基-L-酪氨酰基-L-谷氨酰胺基-L-丝氨酸-N- [2,3,6-三苯氧基-1-O-[(1S,3S)-1排除在外,2,3,4,6 ,11-hexohydro-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1-naththacenyl]-。 Alpha.-L-lixo-hexopyrans-3-yl] -L-prolinamide;和N2-乙酰基-L-高精氨酰基-L-酪氨酰基-L-谷氨酰胺基-L-丝氨酸-L-丝氨酸-N- [2,3,6-三苯氧基-1-O-[(1S,3S)-1.2,3 ,4,6,11-六氢-3,5,12-三hidroxi-3-(hidroxiacetil)-10-metoxi-6 11-dioxo-1-naftacenil-阿尔法-L-lixo-hexopiranos- 3-il -L-纤毛虫

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号